All Funded Investigators
Investigators funded by the ACS IRG award
Investigator | Project Dates | Pilot Project Title |
Kimberly Shea, PhD | April 2012-March 2013 | Vaccine Uptake of Cancer Survivors Identified in the 2009 Behavioral Risk Factor Surveillance System |
Mikel Garcia-Marcos, PhD | April 2012-March 2013 | Towards novel therapeutics for cancer metastasis by targeting a key signaling interface |
Hui Feng, MD, PhD | April 2012-March 2013 | Targeting DLST as a novel therapeutic intervention |
Anurag Singh, PhD | May 2013-April 2014 | Identifying a kras-regulated micro-RNA signaling network in lung cancer |
Gregory A. Russo, MD | May 2013-April 2014 | Feasibility/outcomes study of hypo fractionated stereotactic body radiation therapy as a boost to the prostate for treatment of localized, non-metastatic, high risk prostate cancer |
Darren Roblyer, PhD | May 2013-April 2014 | Real-Time Non-Invasive Optical Markers of Chemotherapy Response for Personalized Adaptive Cancer Treatment |
Marjory Charlot, MD, MPH, MSc | May 2013-April 2014 | Impact of Type 2 Diabetes on Breast Cancer Outcomes in Black Women |
Dmitri Beglov, PhD | May 2013-April 2014 | Computational Selection of Small Molecule Inhabitors of the elF4E:elF4G Protein-Protein Complex Involved in Cancer |
Xaralabos (Bob) Varelas, PhD | April 2014-March 2015 | Defining and Targeting Deregulated Polarity Cues in Breast Cancer |
Trevor Siggers, PhD | April 2014-March 2015 | The role of LSF DNA binding in hepatocellular carcinoma and potential relationship to DNA binding of p53 |
Lisa Quintiliani, PhD | April 2014-March 2015 | Obesity intervention development for cancer prevention among a health disparity population using innovative photovoice methodology (special interest award) |
Xuemei Zhong, PhD | July 2015-December 2015 | Heat-triggered release of immunostimulatory chemokine for cancer immunotherapy |
Jennifer Beane-Ebel, PhD | July 2015-December 2015 | Establishing a preclinical model of squamous lung cancer to investigate novel chemopreventive approaches in high-risk smokers |
Neil Ganem, MD | July 2015-December 2015 | Defining gene expression signatures for YAJP/TAZ-dependent breast cancers |
Hiroshi Tokuo, MD, PhD | July 2015-December 2015 | Mechanism of melanoma metastasis regulated by Myosin-X |
Elizabeth Duffy, MA Joshua Campbell, PhD |
July 2018-June 2019 | “Histological and genomic characterization of premalignancy in prostate cancer from men with African Ancestry” |
Christine Gunn, PhD | July 2018-June 2019 | “Developing Educational Materials for Women with Dense Breasts Using a Multi-Stakeholder Approach” |
Kimberly Mak, MD, MPH | July 2018-June 2019 | “Establishing Routine Measurement of Patient-Reported Outcomes for Radiation Oncology Patients at a Safety Net Hospital” |
Dennis Jones, PhD | February 2019-January 2020 | “Understanding the role of cancer-associated fibroblasts in immune suppression and growth of lymph node metastases” |
Gareth Morgan, PhD | February 2019-January 2020 | “Development of genomic methods for AL amyloidosis” |
Jennifer Rider, ScD, MPH | February 2019-January 2020 | “Patterns in long-term prescription opioid use in patients with cancer who are HIV-infected and HIV-uninfected” |